Trident Lifeline Ltd. (TLL): Trident Lifeline Share Price Rises 10.38% to Rs 301
- September 4, 2026
- Posted by: Harsh Piplani
- Category: News
Trident Lifeline Share Price moved higher today, with the stock trading at Rs 301, up 10.38% from the previous close of Rs 272.7. The company’s market capitalisation now stands at Rs 328.94 Cr, placing Trident Lifeline Share Price in the spotlight across stock market today searches and Stocks in News lists. The latest Univest data confirms the price rise, but it does not establish a company-specific catalyst. Even so, the move is relevant because it comes with a clear change in price action and a noticeable re-rating of investor attention. For readers tracking Trident Lifeline Share Price Today, the key questions are whether the move reflects a broader market update, how the stock looks on fundamentals and how it compares with healthcare peers. Univest keeps the focus on verified numbers and the context that matters for stock analysis.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 301 |
| Previous Close | Rs 272.7 |
| Today's Move | Rs 28.3 (+10.38%) |
| Open | Rs 279 |
| High | Rs 301 |
| Low | Rs 275.1 |
| Turnover | Rs 0.98 crore |
| Market Capitalisation | Rs 328.94 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 301 from the previous close of Rs 272.7, a move of Rs 28.3 or 10.38%. The stock opened at Rs 279, reached a high of Rs 301, recorded a low of Rs 275.1.
Trident Lifeline Share Price opened at Rs 279, touched a low of Rs 275.1 and reached a high of Rs 301, which is also the current traded level. The stock added Rs 28.3 over the previous close, and the gain of 10.38% makes it one of the more visible stocks rising today in the Indian stock market. The turnover stood at Rs 0.98 Cr, which helps frame the scale of the move, while the price action shows that buyers kept the stock near the day’s high. For investors following Trident Lifeline Share Price Live, the important point is simple: the stock has recorded a sharp share price rise, and the latest Univest figures confirm the move without assigning a reason.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 328.94 crore |
| P/E Ratio | 17.12x |
| P/B Ratio | 3.31x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 17.12x, P/B 3.31x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 328.94 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.12x, P/B at 3.31x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.61x, median ROE of 11.79%, median ROCE of 13.66%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.12x |
| Benchmark Median P/E | 32.61x |
| Benchmark Average P/E | 48.83x |
| Benchmark P/E Range | 3.32x to 645.91x |
| Company P/B Ratio | 3.31x |
| Benchmark Median P/B | 2.89x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.66% |
| Company Market Capitalisation | Rs 328.94 crore |
| Benchmark Median Market Cap | Rs 730.27 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 17.12x, which is below the benchmark median of 32.61x, a difference of -47.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.79%, a difference of +59.29%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.66%, a difference of +40.34%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,791.45 | 37.77 | 5.28 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,45,080.59 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,90,351.29 | 85.89 | 20.87 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,832.64 | 25.09 | 4.2 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,162.52 | 33.29 | 3.19 | 11.83 | 16 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 17.12x compared with the displayed peer median of 37.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 328.94 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price rose 10.38% today and is trading near the day high of Rs 301.
- The stock’s P/E of 17.12 is below the same-industry median, which keeps valuation in focus.
- ROE of 18.78% and ROCE of 19.17% are above the industry midpoint.
- Market cap at Rs 328.94 Cr places the company in the smaller-cap segment of healthcare.
- Univest readers are tracking whether this share price rise is supported by broader stock performance trends.
About Trident Lifeline
Trident Lifeline Ltd. is part of the Pharmaceuticals & Drugs industry within the Healthcare sector. The company’s share price is now a key market update because the latest move has pushed Trident Lifeline Share Price to Rs 301 and lifted its market value to Rs 328.94 Cr. For investors using Univest as a stock information source, the company stands out as a smaller healthcare business with valuation and return ratios that can be compared against larger listed names.
Based on the latest Univest figures, Trident Lifeline Share Price is best understood through its core financial metrics rather than through narrative noise. The current reading of P/E, P/B, ROE, ROCE, EPS of Rs 15.92 and book value of Rs 82.4 provides the most direct picture of company quality. Since dividend yield is 0, the stock’s attraction today is coming more from price action and fundamentals than from income-linked appeal.
Frequently Asked Questions
Why is Trident Lifeline Share Price rising today?
Ans. Trident Lifeline Share Price is rising today because the stock gained 10.38% to Rs 301. The latest Univest data confirms the move, but it does not establish a company-specific catalyst.
What is Trident Lifeline Share Price Today?
Ans. Trident Lifeline Share Price Today is Rs 301. It is up Rs 28.3 from the previous close of Rs 272.7, which places the stock among the clearer price gainers in today’s market.
What is the market capitalisation of Trident Lifeline?
Ans. Trident Lifeline has a market capitalisation of Rs 328.94 Cr. That places it in the small-cap category and below the same-industry median market cap of Rs 730.27 Cr.
How does Trident Lifeline look on valuation?
Ans. Trident Lifeline Share Price trades at a P/E of 17.12 and a P/B of 3.31. The P/E is below the industry median, while the P/B is slightly above the median.
What do ROE and ROCE show for Trident Lifeline?
Ans. Trident Lifeline reports ROE of 18.78% and ROCE of 19.17%. Both are above the same-industry medians, which adds useful context to the Trident Lifeline Share Price move. The relevant peer median ROE is 11.79%.
What are the EPS and book value for Trident Lifeline?
Ans. EPS is Rs 15.92 and book value is Rs 82.4 per share. These figures help explain the financial context behind Trident Lifeline Share Price and its current market valuation.
How does Trident Lifeline compare with healthcare peers?
Ans. Trident Lifeline Share Price carries a much smaller market cap than Sun Pharma, Divi’s, Torrent Pharma, Zydus Lifesciences and Cipla. Its P/E is also lower than each of those peers listed here.
Should investors track Trident Lifeline Share Price on Univest?
Ans. Investors tracking Trident Lifeline Share Price can use Univest for live price updates, valuation ratios, market cap, financial results and sector comparison. It is a practical way to follow the stock news in context.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Trident Lifeline Share Price on Univest for live share price updates, stock news, company news, fundamental ratios, market cap, financial results, 52-week levels and market insights. Univest also helps readers follow Trident Lifeline Share Price Today alongside broader sector context, peer comparison and stock analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
